← Evidence map

ReviewDrugs2022

Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis.

Connie Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

43 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34897575